Skip to main content
. 2018 Oct 15;14(10):e1007678. doi: 10.1371/journal.pgen.1007678

Table 1. Somatic missense mutations identified in the samples analyzed.

Tissue Sample
(Date collected)
Blood
(Jan. 2010)
Primary Tumor
(Feb. 2010)
Level IV Lymph Node Metastasis
(Apr. 2010)
Lung Metastasis
(Apr. 2010)
Cervical Lymph Node Metastasis
(Oct. 2012)
Total Variations 1114 1479 3127 8111 1252
Population Frequency Filter (MAF<0.005)
 -1000GP_EU 150 529 2171 7123 294
 - ExAC_NFE 69 443 2089 7031 208
 - ESP6500_Eur 69 443 2088 7031 206
 ClinVar 66 439 2079 7019 206
Quality Filters
 -DP>100 48 214 1422 5699 137
 - GQ>30 44 75 311 482 84
 - SAF/SAR≠ 0 39 67 236 474 72
 - HRUN<6 37 61 232 458 60
 - AF>10% 37 54 143 255 55
Functional Filters
 - Exonic* 10 15 32 30 14
 - Somatic Variants - 5 22 22 4
 - Somatic variants found in all tissues 1 1 1 1

AF: Allele frequency; DP: Depth of Coverage (total read depth at the locus); GQ: Genotype Quality (Phred-scaled marginal (or unconditional) probability of the called genotype); HRUN: Run length (the number of consecutive repeats of alternate allele in the reference genome); SAF/SAR: (Alternative allele observation on the forward strand / Alternative allele observation on the reverse strand).

* Exonic variants included nonsynonymous, stop-gain, stop-loss, splice-site variants and frameshift indels.